| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Biochemistry, University of Western Ontario, London, Canada
When Ehrlich ascites cells were incubated in a suitable medium containing one of a number of 14C-labeled phospholipid precursors, radioactivity was recovered from the lipid fraction. For the same concentration and specific radioactivity of precursor, the incorporation was in the following order: choline-1,2-14C > ethanolamine-1,2-14C > L-serine-14C > glycerol-1-14C > formate-14C > acetate-1-14C.
Radioactivity from choline-1,2-14C was incorporated into the 3 choline-containing phospholipidslecithin, choline plasmalogen, and sphingomyelin. Radioactivity from ethanolamine-1,2-14C was incorporated into phosphatidyl ethanolamine, ethanolamine plasmalogen, choline plasmalogen, and lecithin. Radioactivity from L-serine-14C was incorporated into phosphatidyl serine, serine plasmalogen, and sphingomyelin, and also into phosphatidic acid and other glycerophosphatides. Radioactivity from glycerol-1-14C was incorporated into phosphatidic acid and the glycerophosphatides, and also into sphingomyelin. Radioactivity from formate-14C was incorporated into phosphatidyl serine, serine plasmalogen and sphingomyelin, with lesser amounts into other phosphatides. With acetate-1-14C, radioactivity was poorly incorporated into the phosphatides of this tissue.
These results are discussed in relation to current knowledge concerning the biosynthesis of phosphatides. Evidence is given to support the following generalizations concerning the metabolism of phospholipids in the Ehrlich ascites tumor: (a) The cytosine nucleotide pathway for the biosynthesis of glycerophosphatides is operative. (b) Lipid ethanolamine is methylated to form lipid choline. (c) Phosphatidyl serine is not decarboxylated to yield phosphatidyl ethanolamine.
1 This investigation was supported by grants from the National Cancer Institute and Medical Research Council of Canada.
2 Fellow, National Cancer Institute of Canada.
Received 2/26/65.
Revised 6/ 6/65.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |